Join us on Thursday 28 May, 5:15–6:00pm AEST for an online session designed specifically for those living with the condition now known as Polyendocrine Metabolic Ovarian Syndrome (PMOS).
Previously referred to as PCOS, the condition has been renamed to better reflect its true complexity and impact. Affecting more than 170 million women worldwide, PMOS is a multisystem condition involving hormonal, metabolic, reproductive and mental health features—not simply ovarian cysts.
This name change is the result of 14 years of global advocacy, research, and collaboration, involving 56 organisations, more than 22,000 contributions, and extensive international consultation. Importantly, this work has been driven by lived experience—with women, led by women, and for the 1 in 8 women affected, and for generations to come.
For too long, the previous name created misunderstanding, focusing narrowly on “cysts” despite evidence showing there is no increase in abnormal cysts on the ovary. This misconception has contributed to delayed diagnosis, limited awareness, and gaps in care.
This webinar will provide a space for the community to:
- Understand why the name change happened
- Learn what PMOS means for diagnosis, care and awareness
- Hear from experts and leaders involved in this global initiative
- Explore what’s next for the future of care and research
This is more than a name change—it is a step toward better recognition, better care, and better outcomes for millions of women worldwide
Contact:
Amanda Hamilton
Media and Communications Manager
Monash Centre for Health Research and Implementation (MCHRI)
T: +613 8572 2667, amanda.hamilton@monash.edu
